ANIK Q4 2022 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ANIKAnika Therapeutics, Inc.

$213M

Q4 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$40M+10.6% YoY

Gross Profit

$24M60.9% margin

Operating Income

-$7M-16.8% margin

Net Income

-$5M-12.4% margin

EPS (Diluted)

$-0.34

QoQ Revenue Growth

-1.6%

Cash Flow

Operating Cash Flow

$481,000

Free Cash Flow

-$2M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$349M

Total Liabilities

$64M

Stockholders' Equity

$286M

Cash & Equivalents

$86M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$40M	$36M	+10.6%
Gross Profit	$24M	$18M	+33.1%
Operating Income	-$7M	-$9M	+26.9%
Net Income	-$5M	-$6M	+15.3%

Revenue Segments

OA Pain Management

$24M60%

Joint Preservation and Restoration

$14M36%

Non-Orthopedic

$2M4%

Geographic Segments

UNITED STATES

$32M87%

Europe

$5M13%